Main menu

Genomic hotspots in the DENV-2 serotype (E, NS4B, and NS5 genes) are associated with dengue disease severity in the endemic region of India

Get startedSubscribe
Return to Resources

Dengue fever is a global public health concern, with an estimated 390 million infections each year. Using Oxford Nanopore sequencing, researchers analysed over 3,200 DENV-2 viral genomes from India’s 2023 dengue outbreak, identifying 1.6 million single nucleotide variants (SNVs). With whole-genome analysis, they found clusters of SNVs associated with disease severity — an insight that could guide targeted interventions and inform outbreak response in the future.

Catch Rajesh Pandey’s talk at London Calling 2025 on the Artic Monkeys stage.

Authors: Varsha Ravi, Kriti Khare, Ramakant Mohite, Pallavi Mishra, Sayanti Halder, Richa Shukla, Chinky Shiu Chen Liu, Aanchal Yadav, Jyoti Soni, Kanika, Komal Chaudhary, Neha, Bansidhar Tarai, Sandeep Budhiraja, Pooja Khosla, Tavpritesh Sethi, Md Imran, Rajesh Pandey
Read the full text
  • Published on: April 29 2025
  • Source: PLOS Neglected Tropical Diseases

入門

MinION Starter Packを購入 ナノポア製品の販売 シークエンスサービスプロバイダー グローバルディストリビューター

ナノポア技術

ナノポアの最新ニュースを購読 リソースと発表文献 Nanopore Communityとは

Oxford Nanoporeについて

ニュース 会社沿革 持続可能性 経営陣 メディアリソース & お問い合わせ先 投資家向け パートナー向け Oxford Nanopore社で働く 現在の募集状況 営業上の情報 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust

© 2008 - 2023 Oxford Nanopore Technologies plc. All rights reserved. 登記された事務所：Gosling Building,\n Edmund Halley Road, Oxford Science Park, OX4 4DQ, UK {'|'} 登記番号：05386273 {'|'} VAT番号：336942382。Oxford\n Nanopore Technologies、Wheel icon、EPI2ME、Flongle、GridION、Metrichor、MinION、MinIT、MinKNOW、Plongle、\n PromethION、SmidgION、UbikおよびVolTRAXは様々な国で登録されたOxford Nanopore Technologies\nの商標です。Oxford Nanopore Technologies製品は、\n現在すべて研究用です。

Japanese flag